| Literature DB >> 32718995 |
Takahiro Matsui1, Ryo Tamoto2, Akio Iwasa2, Masafumi Mimura2, Seiji Taniguchi1, Tetsuo Hasegawa1, Takao Sudo1, Hiroki Mizuno1, Junichi Kikuta1, Ichiro Onoyama3, Kaoru Okugawa3, Mayu Shiomi4, Shinya Matsuzaki4, Eiichi Morii5, Tadashi Kimura4, Kiyoko Kato3, Yasujiro Kiyota2, Masaru Ishii6.
Abstract
Histopathologic analysis through biopsy has been one of the most useful methods for the assessment of malignant neoplasms. However, some aspects of the analysis such as invasiveness, evaluation range, and turnaround time from biopsy to report could be improved. Here, we report a novel method for visualizing human cervical tissue three-dimensionally, without biopsy, fixation, or staining, and with sufficient quality for histologic diagnosis. Near-infrared excitation and nonlinear optics were employed to visualize unstained human epithelial tissues of the cervix uteri by constructing images with third-harmonic generation (THG) and second-harmonic generation (SHG). THG images enabled evaluation of nuclear morphology in a quantitative manner with six parameters after image analysis using deep learning. It was also possible to quantitatively assess intraepithelial fibrotic changes based on SHG images and another deep learning analysis. Using each analytical procedure alone, normal and cancerous tissue were classified quantitatively with an AUC ≥0.92. Moreover, a combinatory analysis of THG and SHG images with a machine learning algorithm allowed accurate classification of three-dimensional image files of normal tissue, intraepithelial neoplasia, and invasive carcinoma with a weighted kappa coefficient of 0.86. Our method enables real-time noninvasive diagnosis of cervical lesions, thus constituting a potential tool to dramatically change early detection. SIGNIFICANCE: This study proposes a novel method for diagnosing cancer using nonlinear optics, which enables visualization of histologic features of living tissues without the need for any biopsy or staining dye. ©2020 American Association for Cancer Research.Entities:
Year: 2020 PMID: 32718995 DOI: 10.1158/0008-5472.CAN-20-0348
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701